The Challenges of Pediatric to Adult Care Transitions for Sickle Cell Disease PatientsDanielle Drayton2020-07-02T15:27:45+00:00July 2nd, 2020|Read More
Three Developments That Will Irreversibly Shape the Sickle Cell Disease Therapy MarketDanielle Drayton2020-05-18T16:59:23+00:00May 18th, 2020|Read More
Seven Questions I Would Ask (and Answer) If I Were Developing a New Drug for Sickle Cell DiseaseDanielle Drayton2020-05-07T21:08:11+00:00May 4th, 2020|Read More
The Challenges of Pediatric to Adult Care Transitions for Sickle Cell Disease PatientsDanielle Drayton2020-07-02T15:27:45+00:00July 2nd, 2020|Read More
Three Developments That Will Irreversibly Shape the Sickle Cell Disease Therapy MarketDanielle Drayton2020-05-18T16:59:23+00:00May 18th, 2020|Read More
Seven Questions I Would Ask (and Answer) If I Were Developing a New Drug for Sickle Cell DiseaseDanielle Drayton2020-05-07T21:08:11+00:00May 4th, 2020|Read More
